P0170 Trastuzumab for HER2-positive breast cancer: Experience from a middle-income Asian country von Ho, G.F, Mastura, M.Y, Kaur, R.P, Hoo, L.P, Lim, T.O

Volltext

1833 Prognostic factors in patients with breast cancer and brain metastases: Implications for a resource limited country von Tang, W.H, Ho, G.F, Saad, M, Taib, N.A, See, M.H, Liau, P, Wahid, M.I, Tho, L.M

Volltext

Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer von Zaman, Z.K, Ung, N.M, Malik, R.A, Ho, G.F, Phua, V.C.E, Jamalludin, Z, Baharuldin, M.T.H, Ng, K.H

Volltext

Prevalence and characteristics associated with default of treatment and follow-up in patients with cancer von Chan, C.M.H., Wan Ahmad, W.A., Md Yusof, M., Ho, G.F., Krupat, E.

Volltext

P0140 Second line aflibercept/folfiri chemotherapy in metastatic colorectal cancer in a single institution in a south east asian country: A case series von Mastura, M.Y, Marniza, S, Wan Zamaniah, W.I, Vincent, P, Rozita, A.M, Adlinda, A, Ho, G.F

Volltext

1889 Prospective, non-randomised, open-label study of UDPgluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hor... von Wong, A, Wang, L.Z, Wong, F.C, Ow, S, Nesaretnam, K, Pang, A, Tan, C.S, Lim, Y.W, Ho, G.F, Lee, Y, Yap, H.L, Phang, S, Alip, A.B, Seng, K.Y, Tai, B.C, Walsh, R, Goh, B.C, Lee, S.C

Volltext

OP0005 Performance of predict tool in predicting breast cancer survival in an Asian setting von Wong, H.S, Taib, N.A, Alias, Z, Subramaniam, S, Ng, C.H, Yip, C.H, Ho, G.F, Verkooijen, H.M, Hartman, M, Bhoo-Pathy, N

Volltext

OP0007 What if all cancer patients in Malaysia had access to the best available care: How many deaths are avoidable? von Ho, G.F, Tho, L.M, Mastura, M.Y, Taib, N.A, Yip, C.H, Aina, E.N, Lim, G.C.C, Kaur, R.P, Tharan, S, Singh, M, Dass, A.S, Tan, H.C, Hoo, L.P, Lim, T.O

Volltext

Contralateral Hypertrophy Post Yttrium-90 Transarterial Radioembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus von Hadjivassiliou, Anastasia, Hou, Xinchi, Cardarelli-Leite, Leandro, Klyuzhin, Ivan S, Bénard, François, Klass, Darren, Ho, Stephen G F, Rahmim, Arman, Liu, David

Volltext

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed... von Chen, L.-T., Martinelli, E., Cheng, A.-L., Pentheroudakis, G., Qin, S., Bhattacharyya, G.S., Ikeda, M., Lim, H.-Y., Ho, G.F., Choo, S.P., Ren, Z., Malhotra, H., Ueno, M., Ryoo, B.-Y., Kiang, T.C., Tai, D., Vogel, A., Cervantes, A., Lu, S.-N., Yen, C.-J., Huang, Y.-H., Chen, S.-C., Hsu, C., Shen, Y.-C., Tabernero, J., Yen, Y., Hsu, C.-H., Yoshino, T., Douillard, J.-Y.

Volltext

Radiofrequency ablation followed by resection of malignant liver tumors von Scudamore, Charles H, Lee, Shung I, Patterson, Emma J, Buczkowski, Andrzej K, July, Laura V, Chung, Stephen W, Buckley, Anne R, Ho, Stephen G.F, Owen, David A

Volltext

Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis von Thakor, Avnesh S., MB BChir, MD, PhD, Alshammari, Mohammed T., MD, Liu, David M., MD, Chung, John, MD, Ho, Stephen G.F., MD, Legiehn, Gerald M., MD, Machan, Lindsay, MD, Fischman, Aaron M., MD, Patel, Rahul S., MD, Klass, Darren, MBChB, MD

Volltext

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial von Chan, A.T.C., Lee, V.H.F., Hong, R.-L., Ahn, M.-J., Chong, W.Q., Kim, S.-B., Ho, G.F., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Aziz, M.A.S.A., Ng, Q.S., Yen, C.-J., Soparattanapaisarn, N., Ngan, R.K.-C., Kho, S.K., Tiambeng, M.L.A., Yun, T., Sriuranpong, V., Algazi, A.P., Cheng, A., Massarelli, E., Swaby, R.F., Saraf, S., Yuan, J., Siu, L.L.

Volltext

334P Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Geographic region subgroups in EMPOWER-Lung 1 von Ho, G.F., Sezer, A., Kilickap, S., Gumus, M., Bondarenko, I., Ozguroglu, M., Gogishvili, M., He, X., Gullo, G., Rietschel, P., Quek, R.G.

Volltext

LBA6 A phase II, single arm, open label, Simon two-stage study of pembrolizumab in metastatic HER2-negative breast cancer patients: Evaluation of impact of germline variants in APO... von Ho, G.F., Lee, S.C., Pan, J.W., Bustam, A.Z., Alip, A., Bt Abdul Satar, N.F., Saad, M., Abdul Malik, R., Lim, S.E., Ow, S., Ngoi, N.Y.L., Law, K.B., Toh, Y.Y., Selvam, B., Lim, J., Teo, S-H.

Volltext

1337P Real-world utilization and outcomes of dacomitinib as first-line therapy in Asian patients with advanced EGFR mutation–positive NSCLC: An interim analysis of the ARIA study von Wu, L., Li, J., Xu, C., Biswas, B., Tang, K., Wang, H., Liu, Z., Batra, U., Ho, G.F., Low, S.H.J., Lu, Y., Zhao, M., Tho, L.M., Zhao, J., He, S., Huang, J., Tang, X., Wong, C.H., Wu, Y-L.

Volltext

LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial von Chia, J.W.K., Segelov, E., Deng, Y., Wang, W., Ho, G.F., Sharma, A., Ding, K., Chen, G., Jeffery, G.M., Nott, L.M., Zielinski, R., Ahn, J.B., Chao, T-Y., Yau, T., Nabilah, S., Gandhi, M., Rothwell, P., Simes, J., Ali, R., Toh, H.C.

Volltext

P2.10-03 Mechanisms of Acquired Resistance to ALK Inhibitors Using Plasma Sequencing - Preliminary Data from the ATORG004 Study von Tan, A.C., Seet, A.O.L., Kim, D.-W., Ho, G.F., Ho, J., Liao, B.-C., Tho, L.M., Ahmad, A.R., Reungwetwattana, T., Goto, Y., Sandhir, N., Hsing, S.S., Lee, D.H., Loong, H., Tan, D.S.W.

Volltext

652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemoth... von Toh, H.C., Yang, M-H., Wang, H-M., Hsieh, C-Y., Chitapanarux, I., Ho, K.F., Hong, R-L., Ang, M-K., Colevas, D., Sirachainan, E., Lertbutsayanukul, C., Ho, G.F., Samol, J., Huang, Z., Tan, C., Ding, C., Myo, A.

Volltext

PO-178: A single institutional audit of setup errors for 3DCRT rectal cancers von Chew, W.Z., Jong, W.L., Jamaluddin, Z., Fasha, H., Kadri, A., Mohamad, A., Ho, G.F.

Volltext